Share Price and Basic Stock Data
Last Updated: December 4, 2025, 2:00 am
| PEG Ratio | 7.23 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vera Synthetic Ltd has demonstrated a fluctuating revenue trend over the years, with its sales for the fiscal year ending March 2023 reported at ₹40.70 Cr. This marked an increase from ₹34.98 Cr in FY 2022. The company’s sales trajectory shows resilience, peaking at ₹40.71 Cr in the quarter ending March 2023, although it faced a decline to ₹21.55 Cr in September 2023. Notably, the sales for FY 2024 are anticipated to be ₹39.38 Cr, which indicates a slight contraction compared to FY 2023. The quarterly sales figures reveal volatility, with the highest recorded in March 2023, suggesting a strong seasonal demand or successful product launches. Vera Synthetic’s ability to generate sales from ₹18.01 Cr in September 2019 to a high of ₹40.71 Cr in March 2023 reflects a compounded growth strategy, likely driven by product innovation and market expansion. However, the recent decline in Q2 FY 2024 necessitates close monitoring of market conditions and consumer demand.
Profitability and Efficiency Metrics
The profitability metrics of Vera Synthetic Ltd showcase a mixed performance across different fiscal years. The operating profit margin (OPM) for FY 2023 stood at 7.20%, a decline from 8.72% in FY 2022, reflecting challenges in cost management or pricing power. The net profit for FY 2023 was recorded at ₹1.82 Cr, which is a slight decrease from ₹1.97 Cr in FY 2022. The company’s return on equity (ROE) was reported at 9.07%, indicating a moderate return on shareholders’ investments. The interest coverage ratio (ICR) is exceptionally high at 6735.86x, evidencing a strong capacity to meet interest obligations, which is a significant strength. However, the cash conversion cycle (CCC) of 96.32 days highlights potential inefficiencies in working capital management. Overall, while the company maintains a solid profit margin, the declining trends in net profit and OPM warrant strategic adjustments to enhance profitability.
Balance Sheet Strength and Financial Ratios
Vera Synthetic Ltd’s balance sheet reflects a robust financial position, characterized by minimal borrowings of just ₹0.03 Cr, which underscores a low leverage profile. The company’s total assets stood at ₹26.74 Cr as of March 2025, with reserves increasing to ₹20.00 Cr, indicating a strong capital base. The current ratio of 5.44x suggests excellent liquidity, far exceeding industry norms, which typically range from 1.5x to 2.5x. Furthermore, the price-to-book value (P/BV) ratio is recorded at 1.42x, indicating that the market values the company at a premium relative to its book value. The return on capital employed (ROCE) at 12.26% is moderately strong, although it has shown a declining trend from previous years. These financial ratios indicate a well-capitalized firm with the potential for sustainable growth, but the decreasing trend in ROCE may require attention to maintain investor confidence.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vera Synthetic Ltd reveals a strong promoter holding of 68.66%, which has seen a steady increase from 59.86% in March 2020. This significant promoter stake is a positive indicator of management confidence in the company’s future prospects. Public shareholding stands at 31.34%, reflecting a balanced distribution of ownership. The number of shareholders has also increased to 115, suggesting growing interest among retail investors. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may point to a lack of institutional support, which can impact stock liquidity and valuation. The consistent promoter stake coupled with rising retail interest may bolster investor confidence, but the reliance on public shareholders without institutional backing poses a risk, particularly in market downturns.
Outlook, Risks, and Final Insight
The outlook for Vera Synthetic Ltd is contingent on its ability to navigate the challenges posed by fluctuating sales and profitability metrics. Key strengths include a low debt level, high interest coverage, and strong promoter support, all of which provide a solid foundation for future growth. Conversely, risks such as declining net profit margins, high cash conversion cycles, and lack of institutional investment could hinder performance. Should the company effectively address operational efficiencies and enhance its product offerings, it may capitalize on market opportunities. Conversely, failure to adapt to market demands could lead to further revenue declines. Overall, while the company possesses fundamental strengths, its future performance hinges on strategic initiatives to improve profitability and operational efficiency.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Vera Synthetic Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 105 Cr. | 27.4 | 827/26.3 | 1.02 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 1,721 Cr. | 170 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 48.4 Cr. | 3.79 | 8.65/3.55 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,880.64 Cr | 225.01 | 430.29 | 219.29 | 0.25% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.01 | 15.56 | 14.70 | 13.43 | 17.40 | 17.58 | 19.61 | 40.71 | 21.55 | 21.56 | 23.28 | 19.11 |
| Expenses | 16.37 | 13.97 | 12.42 | 13.36 | 16.57 | 15.35 | 17.93 | 37.78 | 21.21 | 20.26 | 21.23 | 17.52 |
| Operating Profit | 1.64 | 1.59 | 2.28 | 0.07 | 0.83 | 2.23 | 1.68 | 2.93 | 0.34 | 1.30 | 2.05 | 1.59 |
| OPM % | 9.11% | 10.22% | 15.51% | 0.52% | 4.77% | 12.68% | 8.57% | 7.20% | 1.58% | 6.03% | 8.81% | 8.32% |
| Other Income | 0.00 | 0.00 | 0.00 | 1.03 | 0.31 | -0.05 | 0.05 | 0.17 | 0.01 | 0.00 | 0.11 | 0.00 |
| Interest | 0.10 | 0.09 | 0.07 | 0.09 | 0.07 | 0.09 | 0.07 | 0.16 | 0.05 | 0.05 | 0.00 | 0.00 |
| Depreciation | 0.31 | 0.37 | 0.30 | 0.31 | 0.34 | 0.17 | 0.21 | 0.49 | 0.54 | 0.54 | 0.49 | 0.53 |
| Profit before tax | 1.23 | 1.13 | 1.91 | 0.70 | 0.73 | 1.92 | 1.45 | 2.45 | -0.24 | 0.71 | 1.67 | 1.06 |
| Tax % | 27.64% | 15.93% | 29.84% | 27.14% | 26.03% | 25.52% | 24.14% | 25.71% | 4.17% | 25.35% | 25.15% | 27.36% |
| Net Profit | 0.90 | 0.96 | 1.35 | 0.51 | 0.54 | 1.42 | 1.09 | 1.82 | -0.25 | 0.53 | 1.26 | 0.77 |
| EPS in Rs | 1.82 | 1.95 | 2.74 | 1.03 | 1.09 | 2.88 | 2.21 | 3.69 | -0.51 | 1.07 | 2.55 | 1.56 |
Last Updated: August 20, 2025, 1:30 am
Below is a detailed analysis of the quarterly data for Vera Synthetic Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 19.11 Cr.. The value appears to be declining and may need further review. It has decreased from 23.28 Cr. (Sep 2024) to 19.11 Cr., marking a decrease of 4.17 Cr..
- For Expenses, as of Mar 2025, the value is 17.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 21.23 Cr. (Sep 2024) to 17.52 Cr., marking a decrease of 3.71 Cr..
- For Operating Profit, as of Mar 2025, the value is 1.59 Cr.. The value appears to be declining and may need further review. It has decreased from 2.05 Cr. (Sep 2024) to 1.59 Cr., marking a decrease of 0.46 Cr..
- For OPM %, as of Mar 2025, the value is 8.32%. The value appears to be declining and may need further review. It has decreased from 8.81% (Sep 2024) to 8.32%, marking a decrease of 0.49%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 0.11 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.53 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.49 Cr. (Sep 2024) to 0.53 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Mar 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 1.67 Cr. (Sep 2024) to 1.06 Cr., marking a decrease of 0.61 Cr..
- For Tax %, as of Mar 2025, the value is 27.36%. The value appears to be increasing, which may not be favorable. It has increased from 25.15% (Sep 2024) to 27.36%, marking an increase of 2.21%.
- For Net Profit, as of Mar 2025, the value is 0.77 Cr.. The value appears to be declining and may need further review. It has decreased from 1.26 Cr. (Sep 2024) to 0.77 Cr., marking a decrease of 0.49 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.56. The value appears to be declining and may need further review. It has decreased from 2.55 (Sep 2024) to 1.56, marking a decrease of 0.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:10 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.58 | 24.32 | 21.89 | 18.13 | 22.15 | 33.73 | 32.29 | 27.76 | 34.98 | 40.70 | 39.38 | 42.03 |
| Expenses | 18.67 | 23.37 | 21.02 | 17.17 | 19.86 | 31.03 | 29.22 | 25.43 | 31.93 | 37.77 | 35.74 | 38.60 |
| Operating Profit | 0.91 | 0.95 | 0.87 | 0.96 | 2.29 | 2.70 | 3.07 | 2.33 | 3.05 | 2.93 | 3.64 | 3.43 |
| OPM % | 4.65% | 3.91% | 3.97% | 5.30% | 10.34% | 8.00% | 9.51% | 8.39% | 8.72% | 7.20% | 9.24% | 8.16% |
| Other Income | 0.18 | 0.18 | 0.06 | 0.02 | 0.10 | 0.17 | 0.17 | 1.05 | 0.26 | 0.17 | 0.07 | 0.33 |
| Interest | 0.33 | 0.35 | 0.13 | 0.10 | 0.37 | 0.25 | 0.19 | 0.16 | 0.16 | 0.16 | 0.08 | 0.00 |
| Depreciation | 0.28 | 0.38 | 0.40 | 0.26 | 0.48 | 0.65 | 0.67 | 0.61 | 0.51 | 0.49 | 1.18 | 1.02 |
| Profit before tax | 0.48 | 0.40 | 0.40 | 0.62 | 1.54 | 1.97 | 2.38 | 2.61 | 2.64 | 2.45 | 2.45 | 2.74 |
| Tax % | 31.25% | 90.00% | 32.50% | 32.26% | 31.17% | 28.93% | 21.85% | 28.74% | 25.76% | 25.71% | 27.35% | 25.91% |
| Net Profit | 0.33 | 0.05 | 0.27 | 0.43 | 1.06 | 1.40 | 1.85 | 1.86 | 1.97 | 1.82 | 1.80 | 2.03 |
| EPS in Rs | 1.83 | 0.28 | 1.50 | 2.39 | 2.94 | 2.84 | 3.75 | 3.77 | 3.99 | 3.69 | 3.65 | 4.11 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -84.85% | 440.00% | 59.26% | 146.51% | 32.08% | 32.14% | 0.54% | 5.91% | -7.61% | -1.10% | 12.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | 524.85% | -380.74% | 87.25% | -114.44% | 0.07% | -31.60% | 5.37% | -13.53% | 6.52% | 13.88% |
Vera Synthetic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 45% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | % |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:11 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.80 | 1.80 | 1.80 | 1.80 | 3.60 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 |
| Reserves | 1.61 | 2.40 | 2.67 | 2.33 | 1.58 | 6.70 | 8.55 | 10.41 | 12.38 | 14.20 | 15.99 | 18.02 | 20.00 |
| Borrowings | 3.31 | 1.27 | 0.81 | 0.85 | 5.01 | 1.76 | 1.40 | 1.82 | 1.68 | 1.13 | 0.00 | 0.00 | 0.03 |
| Other Liabilities | 1.79 | 1.59 | 2.04 | 2.89 | 5.12 | 2.29 | 3.37 | 3.44 | 4.52 | 2.92 | 2.52 | 3.78 | 5.65 |
| Total Liabilities | 8.51 | 7.06 | 7.32 | 7.87 | 15.31 | 15.69 | 18.26 | 20.61 | 23.52 | 23.19 | 23.45 | 26.74 | 30.62 |
| Fixed Assets | 2.01 | 2.41 | 2.40 | 1.06 | 3.45 | 3.97 | 4.01 | 4.47 | 3.05 | 6.08 | 6.57 | 5.65 | 5.27 |
| CWIP | 0.37 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 6.13 | 4.28 | 4.92 | 6.81 | 11.86 | 11.72 | 14.25 | 16.14 | 20.47 | 17.11 | 16.88 | 21.09 | 25.35 |
| Total Assets | 8.51 | 7.06 | 7.32 | 7.87 | 15.31 | 15.69 | 18.26 | 20.61 | 23.52 | 23.19 | 23.45 | 26.74 | 30.62 |
Below is a detailed analysis of the balance sheet data for Vera Synthetic Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.94 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.94 Cr..
- For Reserves, as of Sep 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.02 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 1.98 Cr..
- For Borrowings, as of Sep 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.03 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.78 Cr. (Mar 2025) to 5.65 Cr., marking an increase of 1.87 Cr..
- For Total Liabilities, as of Sep 2025, the value is 30.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.74 Cr. (Mar 2025) to 30.62 Cr., marking an increase of 3.88 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5.27 Cr.. The value appears to be declining and may need further review. It has decreased from 5.65 Cr. (Mar 2025) to 5.27 Cr., marking a decrease of 0.38 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 25.35 Cr.. The value appears strong and on an upward trend. It has increased from 21.09 Cr. (Mar 2025) to 25.35 Cr., marking an increase of 4.26 Cr..
- For Total Assets, as of Sep 2025, the value is 30.62 Cr.. The value appears strong and on an upward trend. It has increased from 26.74 Cr. (Mar 2025) to 30.62 Cr., marking an increase of 3.88 Cr..
Notably, the Reserves (20.00 Cr.) exceed the Borrowings (0.03 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -2.40 | -0.32 | 0.06 | 0.11 | -2.72 | 0.94 | 1.67 | 0.51 | 1.37 | 1.80 | 3.64 | 3.43 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54.81 | 46.83 | 45.69 | 36.04 | 136.28 | 82.67 | 92.01 | 83.36 | 89.01 | 82.15 | 27.06 | 37.95 |
| Inventory Days | 50.65 | 13.18 | 21.15 | 31.97 | 38.30 | 5.46 | 28.52 | 51.60 | 30.23 | 38.86 | 68.81 | 84.39 |
| Days Payable | 11.54 | 10.23 | 16.10 | 7.05 | 81.62 | 16.38 | 23.50 | 33.41 | 37.57 | 14.65 | 7.57 | 26.02 |
| Cash Conversion Cycle | 93.91 | 49.77 | 50.74 | 60.97 | 92.96 | 71.76 | 97.02 | 101.55 | 81.67 | 106.36 | 88.30 | 96.32 |
| Working Capital Days | 36.54 | 20.86 | 23.18 | 5.44 | 45.98 | 70.01 | 86.02 | 117.68 | 134.61 | 101.88 | 80.17 | 143.99 |
| ROCE % | 12.31% | 9.86% | 14.04% | 25.18% | 18.82% | 17.96% | 16.47% | 15.48% | 13.29% | 12.28% | 12.26% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Diluted EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Cash EPS (Rs.) | 6.18 | 6.02 | 4.67 | 5.01 | 4.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Revenue From Operations / Share (Rs.) | 85.44 | 79.80 | 82.48 | 70.89 | 56.95 |
| PBDIT / Share (Rs.) | 7.62 | 7.53 | 6.28 | 6.71 | 6.85 |
| PBIT / Share (Rs.) | 5.54 | 5.15 | 5.30 | 5.68 | 5.62 |
| PBT / Share (Rs.) | 5.54 | 4.98 | 4.97 | 5.36 | 5.29 |
| Net Profit / Share (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| PBDIT Margin (%) | 8.91 | 9.43 | 7.61 | 9.46 | 12.03 |
| PBIT Margin (%) | 6.48 | 6.44 | 6.42 | 8.01 | 9.86 |
| PBT Margin (%) | 6.48 | 6.24 | 6.02 | 7.56 | 9.28 |
| Net Profit Margin (%) | 4.80 | 4.56 | 4.46 | 5.62 | 6.60 |
| Return on Networth / Equity (%) | 8.83 | 8.58 | 9.51 | 11.36 | 12.09 |
| Return on Capital Employeed (%) | 11.91 | 12.13 | 13.28 | 15.23 | 16.66 |
| Return On Assets (%) | 7.57 | 7.65 | 7.84 | 8.36 | 9.00 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.02 | 0.06 | 0.08 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.05 | 0.09 | 0.08 |
| Asset Turnover Ratio (%) | 1.68 | 1.69 | 1.74 | 1.59 | 1.45 |
| Current Ratio (X) | 5.44 | 6.58 | 4.80 | 3.95 | 4.00 |
| Quick Ratio (X) | 3.72 | 4.56 | 3.91 | 3.55 | 3.38 |
| Inventory Turnover Ratio (X) | 4.08 | 4.29 | 7.26 | 5.38 | 4.94 |
| Interest Coverage Ratio (X) | 6735.86 | 44.96 | 19.25 | 21.30 | 20.70 |
| Interest Coverage Ratio (Post Tax) (X) | 3633.34 | 22.73 | 12.29 | 13.66 | 12.35 |
| Enterprise Value (Cr.) | 32.30 | 20.24 | 35.29 | 12.33 | 14.28 |
| EV / Net Operating Revenue (X) | 0.76 | 0.51 | 0.86 | 0.35 | 0.50 |
| EV / EBITDA (X) | 8.59 | 5.45 | 11.38 | 3.73 | 4.22 |
| MarketCap / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| Price / BV (X) | 1.42 | 1.23 | 1.89 | 0.74 | 1.04 |
| Price / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| EarningsYield | 0.06 | 0.06 | 0.05 | 0.15 | 0.11 |
After reviewing the key financial ratios for Vera Synthetic Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.18. This value is within the healthy range. It has increased from 6.02 (Mar 24) to 6.18, marking an increase of 0.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.51. It has increased from 42.41 (Mar 24) to 46.51, marking an increase of 4.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.51. It has increased from 42.41 (Mar 24) to 46.51, marking an increase of 4.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 85.44. It has increased from 79.80 (Mar 24) to 85.44, marking an increase of 5.64.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.62. This value is within the healthy range. It has increased from 7.53 (Mar 24) to 7.62, marking an increase of 0.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has increased from 5.15 (Mar 24) to 5.54, marking an increase of 0.39.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has increased from 4.98 (Mar 24) to 5.54, marking an increase of 0.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For PBDIT Margin (%), as of Mar 25, the value is 8.91. This value is below the healthy minimum of 10. It has decreased from 9.43 (Mar 24) to 8.91, marking a decrease of 0.52.
- For PBIT Margin (%), as of Mar 25, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.44 (Mar 24) to 6.48, marking an increase of 0.04.
- For PBT Margin (%), as of Mar 25, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.24 (Mar 24) to 6.48, marking an increase of 0.24.
- For Net Profit Margin (%), as of Mar 25, the value is 4.80. This value is below the healthy minimum of 5. It has increased from 4.56 (Mar 24) to 4.80, marking an increase of 0.24.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.83. This value is below the healthy minimum of 15. It has increased from 8.58 (Mar 24) to 8.83, marking an increase of 0.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.91. This value is within the healthy range. It has decreased from 12.13 (Mar 24) to 11.91, marking a decrease of 0.22.
- For Return On Assets (%), as of Mar 25, the value is 7.57. This value is within the healthy range. It has decreased from 7.65 (Mar 24) to 7.57, marking a decrease of 0.08.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.68. It has decreased from 1.69 (Mar 24) to 1.68, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 5.44. This value exceeds the healthy maximum of 3. It has decreased from 6.58 (Mar 24) to 5.44, marking a decrease of 1.14.
- For Quick Ratio (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 2. It has decreased from 4.56 (Mar 24) to 3.72, marking a decrease of 0.84.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.08. This value is within the healthy range. It has decreased from 4.29 (Mar 24) to 4.08, marking a decrease of 0.21.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6,735.86. This value is within the healthy range. It has increased from 44.96 (Mar 24) to 6,735.86, marking an increase of 6,690.90.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3,633.34. This value is within the healthy range. It has increased from 22.73 (Mar 24) to 3,633.34, marking an increase of 3,610.61.
- For Enterprise Value (Cr.), as of Mar 25, the value is 32.30. It has increased from 20.24 (Mar 24) to 32.30, marking an increase of 12.06.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 24) to 0.76, marking an increase of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 8.59. This value is within the healthy range. It has increased from 5.45 (Mar 24) to 8.59, marking an increase of 3.14.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.77, marking an increase of 0.12.
- For Price / BV (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.42, marking an increase of 0.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.77, marking an increase of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vera Synthetic Ltd:
- Net Profit Margin: 4.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.91% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.83% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3633.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.6 (Industry average Stock P/E: 430.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.8%
Fundamental Analysis of Vera Synthetic Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Synthetic/Silk | Office No.UL-27, Bhavnagar Gujarat 364002 | info@sujlonropes.com http://www.sujlonropes.com |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Meera S Makwana | Whole Time Director |
| Mr. Devjibhai P Makwana | Executive Director |
| Mr. Ravikumar B Adhiya | Independent Director |
| Mr. Dineshbhai M Patel | Independent Director |
| Mrs. Divyaben H Mehta | Independent Director |
| Mr. Sunil D Makwana | Chairman & Managing Director |
Vera Synthetic Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹47.00 |
| Previous Day | ₹47.00 |
FAQ
What is the intrinsic value of Vera Synthetic Ltd?
Vera Synthetic Ltd's intrinsic value (as of 05 December 2025) is 47.09 which is 32.63% lower the current market price of 69.90, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 34.5 Cr. market cap, FY2025-2026 high/low of 118/66.0, reserves of ₹20.00 Cr, and liabilities of 30.62 Cr.
What is the Market Cap of Vera Synthetic Ltd?
The Market Cap of Vera Synthetic Ltd is 34.5 Cr..
What is the current Stock Price of Vera Synthetic Ltd as on 05 December 2025?
The current stock price of Vera Synthetic Ltd as on 05 December 2025 is 69.9.
What is the High / Low of Vera Synthetic Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vera Synthetic Ltd stocks is 118/66.0.
What is the Stock P/E of Vera Synthetic Ltd?
The Stock P/E of Vera Synthetic Ltd is 12.6.
What is the Book Value of Vera Synthetic Ltd?
The Book Value of Vera Synthetic Ltd is 50.5.
What is the Dividend Yield of Vera Synthetic Ltd?
The Dividend Yield of Vera Synthetic Ltd is 0.00 %.
What is the ROCE of Vera Synthetic Ltd?
The ROCE of Vera Synthetic Ltd is 12.3 %.
What is the ROE of Vera Synthetic Ltd?
The ROE of Vera Synthetic Ltd is 9.07 %.
What is the Face Value of Vera Synthetic Ltd?
The Face Value of Vera Synthetic Ltd is 10.0.